Literature DB >> 19131653

Upregulation of macrophage migration inhibitory factor gene expression in stroke.

Lijuan Wang, Odysseus Zis, Guixian Ma, Zhixin Shan, Xiong Zhang, Shuo Wang, Chengbo Dai, Jiehao Zhao, Qiuxiong Lin, Shuguang Lin, Weihong Song.   

Abstract

BACKGROUND AND
PURPOSE: MIF has been implicated to function in many inflammatory processes. This study examined whether MIF expression was affected in stroke and its underlying molecular mechanism.
METHODS: ELISA and qRT-PCR were used to detect MIF protein and mRNA in PBMCs from stroke patients, the ischemic rat brains, and controls. A MIF promoter assay under hypoxia was performed.
RESULTS: MIF protein and mRNA were significantly increased in stroke patients. Increasing levels of MIF were correlated to the severity of stroke and peaked 24 hours after stroke. MIF was significantly upregulated in focal ischemic rat brains. The activity of the human MIF promoter was significantly increased under hypoxia compared to normoxia.
CONCLUSIONS: MIF gene expression is upregulated after stroke, and hypoxia signaling plays an important role in upregulation of MIF expression under stroke.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131653     DOI: 10.1161/STROKEAHA.108.530535

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke.

Authors:  Guangjie Wang; Chuanbin Li; Yashou Liu; Lei Xia
Journal:  Neurotox Res       Date:  2018-12-01       Impact factor: 3.911

2.  Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.

Authors:  Amanda Ellis; Julie Wieseler; Jacob Favret; Kirk W Johnson; Kenner C Rice; Steven F Maier; Scott Falci; Linda R Watkins
Journal:  J Pain       Date:  2014-01-09       Impact factor: 5.820

3.  Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.

Authors:  Liu Yang; Ying Kong; Honglei Ren; Minshu Li; Chang-Juan Wei; Elaine Shi; Wei-Na Jin; Junwei Hao; Arthur A Vandenbark; Halina Offner
Journal:  Neurochem Int       Date:  2016-11-21       Impact factor: 3.921

4.  Expression of macrophage migration inhibitory factor in the mouse neocortex and posterior piriform cortices during postnatal development.

Authors:  Wei Zhang; Lingling Li; Jiutao Wang; Lei An; Xinde Hu; Jiongfang Xie; Runchuan Yan; Shulin Chen; Shanting Zhao
Journal:  Cell Mol Neurobiol       Date:  2014-08-14       Impact factor: 5.046

Review 5.  Partial MHC class II constructs as novel immunomodulatory therapy for stroke.

Authors:  Gil Benedek; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Neurochem Int       Date:  2016-10-31       Impact factor: 3.921

6.  Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.

Authors:  Ana R Inácio; Karsten Ruscher; Lin Leng; Richard Bucala; Tomas Deierborg
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-10       Impact factor: 6.200

7.  Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice.

Authors:  L Christine Turtzo; Jun Li; Rebecca Persky; Sharon Benashski; Gillian Weston; Richard Bucala; Venugopal Reddy Venna; Louise D McCullough
Journal:  Neurobiol Dis       Date:  2013-01-30       Impact factor: 5.996

8.  Hypoxia signaling regulates macrophage migration inhibitory factor (MIF) expression in stroke.

Authors:  Odysseus Zis; Si Zhang; Katerina Dorovini-Zis; Lijuan Wang; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

9.  Down-regulation of MIF by NFκB under hypoxia accelerated neuronal loss during stroke.

Authors:  Si Zhang; Odysseus Zis; Philip T T Ly; Yili Wu; Shuting Zhang; Mingming Zhang; Fang Cai; Richard Bucala; Woei-Cherng Shyu; Weihong Song
Journal:  FASEB J       Date:  2014-06-26       Impact factor: 5.191

10.  Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses.

Authors:  Marie-Claude Audet; Hymie Anisman
Journal:  Front Cell Neurosci       Date:  2013-05-10       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.